News
Networking ‘ at Forum of Health and Innovation
On December 2nd took place in the Hotel Hesperia Tower the Forum of Health and Innovation organized by the LH innova program of the Hospitalet City Council in collaboration with the IDIBELL. The opening of the conference was attended by the mayor of L’ Hospitalet, Núria Marín, the delegate of the Chamber of Commerce in […]
Interactions between genes explain part of the heritability of cancer risk
An international study led by researcher Miguel Angel Pujana of the Bellvitge Institute of Biomedical Research (IDIBELL) and the Catalan Institute of Oncology (ICO) describes a new method that could allow the identification of genetic interactions associated with cancer risk. Genome-wide association studies (ie GWAS) has identified dozens of common genetic variants associated with cancer […]
IDIBELL researcher Antonio Agudo received a special mention at the Pfizer Foundation Awards
Agudo published in the Journal of Clinical Oncology that concluded that 20 percent of all tumors are caused directly by the consumption of snuff The Pfizer Foundation gave the Thursday, November 28, its annual awards Biomedicine. The event, held in Barcelona, distinguished five medical researches on pneumococcal infections in children, lymphatic leukemia, colorectal cancer, […]
Why tumors become resistant to chemotherapy?
IDIBELL Researchers describe epigenetic changes that explain the lack of response to drugs in colon cancer Article reference
Princess of Asturias delivers King Jaime I Awards 2013
IDIBELL researcher Manel Esteller has been awarded in the category of basic research
Researchers describe one mechanism that favors rejection in transplantation of porcine cartilage in humans
Inhibition of the complement system protects the transplant of pig cartilage cells Complement system Description of the mechanism Cartilage transplant
Juan Ortin:”The defining characteristic of influenza virus is its unpredictability”
Influenza virus attacks us every year and occasionally can cause pandemics with high morbidity and mortality. This virus is the object of study team led by researcher John Ortín the National Center of Biotechnology, CSIC, Madrid. Juan Ortín explained in a conference within IDIBELL seminars on 8 November, the progress of his research on the […]
Health Connect-EU presents Strategic Agenda in Health Research 2013
ICO , IDIBELL and HUB are part of this network that aims to position health research is done in Catalonia in Europe
ICO publishes 2012 sustainability report
The Catalan Institute of Oncology (ICO) has published its first sustainability report, which has been developed according to the criteria of the Global Reporting Initiative (GRI) Level A, maximum application. The report, which has been approved by the Management Board, follows the strategic lines of the institution, which has among its objectives to ensure the […]